NCT00854828

Brief Summary

This is a multicenter study evaluating the effectiveness of nonoperative and operative treatments. The investigators wish to identify important clinical and radiographic determinants of outcomes in the management of adults with symptomatic lumbar scoliosis (ASLS). Note: Enrollment was complete July 2014. National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) funding ended 2/28/17. We continue to follow enrolled subjects while we seek additional funding to follow all subjects through 8 years.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
286

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2010

Longer than P75 for not_applicable

Geographic Reach
2 countries

9 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 2, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

March 3, 2009

Completed
1.1 years until next milestone

Study Start

First participant enrolled

April 1, 2010

Completed
6.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2017

Completed
4.5 years until next milestone

Results Posted

Study results publicly available

September 14, 2021

Completed
Last Updated

September 14, 2021

Status Verified

August 1, 2021

Enrollment Period

6.9 years

First QC Date

March 2, 2009

Results QC Date

June 2, 2021

Last Update Submit

September 10, 2021

Conditions

Keywords

Symptomatic 40-80 y/o w/lumbar Cobb of 30 degreesAll Participants must be reasonable surgical candidate at enrollment

Outcome Measures

Primary Outcomes (2)

  • Scoliosis Research Society Quality of Life Questionnaire (SRS QOL) Subscore

    Change was calculated as the SRS QOL Subscore value at 2-year minus the value at Baseline for Randomized Cohort (Intent-to-Treat analysis). SRS QOL Subscore value range is 1 to 5, where 5 is the best score and 1 is the worst score possible.

    Baseline, 2-year

  • Scoliosis Research Society Quality of Life (SRS QOL) Subscore

    Change was calculated as the SRS QOL Subscore value at 2-year as-treated follow-up minus the value at Baseline in the Observational cohort. SRS QOL Subscore value range is 1 to 5, where 5 is the best score and 1 is the worst score possible.

    Baseline, 2-year

Secondary Outcomes (2)

  • Oswestry Disability Index (ODI) - Randomized Cohort

    Baseline, 2-year

  • Oswestry Disability Index (ODI)

    Baseline, 2-year

Study Arms (2)

Surgical Intervention

ACTIVE COMPARATOR
Procedure: Surgical intervention

Non-Operative Intervention

ACTIVE COMPARATOR
Other: Non-operative intervention

Interventions

Surgical intervention as appropriate for adults with symptomatic lumbar scoliosis

Surgical Intervention

Non operative intervention as appropriate for treatment of adults with symptomatic lumbar scoliosis such as: injections, medications, physical therapy, etc.

Non-Operative Intervention

Eligibility Criteria

Age40 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • aged 40 to 80 years with
  • ASLS defined as lumbar curve with a coronal Cobb measurement ≥ 30°, and either of the following: Oswestry Disability Index (ODI) score ≥ 20 or SRS-QOL score ≤ 4.0 in the domains of pain, function and/or appearance.
  • If assigned to surgical intervention (by randomization or patient preference), the intervention plan would include, at a minimum, the Cobb levels of the Thoracolumbar/lumbar spine.

You may not qualify if:

  • Substantial cardiac, pulmonary, renal or metabolic disease that, in the judgment of the surgical team, would preclude performing an operative procedure without undue risk of morbidity and mortality
  • Concomitant high-grade spondylolisthesis (Grade 3)
  • Prior thoracic or lumbar fusion
  • Osteoporosis evidence by a dual-energy x-ray absorptiometry (DEXA) T-score \<-3.0 at hip or lumbar spine for patients considered to be at risk (post menopausal females, males \> 60 years of age, steroid dependent rheumatoid arthritics, status post organ transplantation, etc.). Patients may be randomized prior to obtaining DEXA results. Non Surgical patients may initiate non surgical treatments prior to completion of DEXA (if required) as non surgical treatments will not affect DEXA results but DEXA must be completed and results entered within 3 months of enrollment. Surgical patient must have DEXA prior to surgical intervention.
  • Neuromuscular scoliosis (e.g., spinal muscular atrophy, cerebral palsy, Parkinson's Disease, post-polio syndrome, Charcot Marie Tooth disease)
  • Congenital scoliosis in the lumbar spine. Congenital anomalies of the cervical or thoracic spine are acceptable.
  • Spine tumor, infection or connective tissue disorder
  • Cognitively impaired or unable/unwilling to comply with follow-up
  • Pregnancy or planning on conceiving during time of study involvement
  • Ankylosing Spondylitis
  • Past history of vertebroplasty or kyphoplasty of the thoracic or lumbar spine

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (9)

Northwestern University

Chicago, Illinois, 60611, United States

Location

University of Louisville

Louisville, Kentucky, 40202, United States

Location

Maryland Spine Center

Baltimore, Maryland, 21212, United States

Location

Washington University

St Louis, Missouri, 63110, United States

Location

New York University

New York, New York, 10010, United States

Location

Hospital for Special Surgery

New York, New York, 10021, United States

Location

University of Virginia

Charlottesville, Virginia, 22908, United States

Location

Toronto Western Hospital

Toronto, Ontario, M5T 2S8, Canada

Location

Hopital du Sacre'

Montreal, Quebec, HrJ 1C5, Canada

Location

Related Publications (2)

  • Smith JS, Kelly MP, Yanik EL, Baldus CR, Pham V, Ben-Israel D, Lurie JD, Edwards C, Glassman SD, Lenke LG, Buchowski JM, Carreon LY, Crawford CH 3rd, Lewis SJ, Koski T, Lafage V, Gupta MC, Kim HJ, Ames CP, Bess S, Schwab FJ, Shaffrey CI, Bridwell KH. Operative vs Nonoperative Treatment for Adult Symptomatic Lumbar Scoliosis at 8-Year Follow-Up: A Nonrandomized Clinical Trial. JAMA Surg. 2025 Jun 1;160(6):634-644. doi: 10.1001/jamasurg.2025.0496.

  • Dial BL, Hills JM, Smith JS, Sardi JP, Lazaro B, Shaffrey CI, Bess S, Schwab FJ, Lafage V, Lafage R, Kelly MP, Bridwell KH. The impact of lumbar alignment targets on mechanical complications after adult lumbar scoliosis surgery. Eur Spine J. 2022 Jun;31(6):1573-1582. doi: 10.1007/s00586-022-07200-3. Epub 2022 Apr 15.

MeSH Terms

Conditions

Scoliosis

Interventions

Surgical Procedures, Operative

Condition Hierarchy (Ancestors)

Spinal CurvaturesSpinal DiseasesBone DiseasesMusculoskeletal Diseases

Results Point of Contact

Title
Keith H. Bridwell, MD
Organization
Washington University

Study Officials

  • Keith H Bridwell, MD

    Washington University School of Medicine

    PRINCIPAL INVESTIGATOR
  • Jon Lurie, MD

    Dartmouth-Hitchcock Medical Center

    STUDY DIRECTOR
  • Christopher Shaffrey, MD

    University of Virginia

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: There were 2 cohorts: Randomized and Observational, each with an operative and non-operative arm.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 2, 2009

First Posted

March 3, 2009

Study Start

April 1, 2010

Primary Completion

February 28, 2017

Study Completion

February 28, 2017

Last Updated

September 14, 2021

Results First Posted

September 14, 2021

Record last verified: 2021-08

Locations